Transcription of 40造血細胞移植 Program 1211 - congre.co.jp
{{id}} {{{paragraph}}}
Example: bankruptcy
40造血細胞移植 Program 1211 - congre.co.jp
17 2 2 2 2-3-1 191 3 2 2 2 9:00 10:00 GVHD GVHD basic research O2-3-1 1 T Analysis of "minimal residual recipient T cells" after allo-HSCT by high-throughput sequencing 1 1 2 2 2 2 2 2 2 1 1 3 4 5 1 1 2 3 4 5 O2-3-1 2 Exosome Exosome Derived from Human Umbilical Cord and Amnion: Comparison of Immunosuppressive Ability 1 2, 3 1 1 1 1 2, 3 1 3 1 1 2 3 O2-3-1 3 5- GVHD Visible Light-based Photodynamic Therapy for Graft-versus-Host Disease O2-3-1 4 Inhibitors of apoptosis proteins IAPs are required for protecting gastroi
－20－ O2-4-1（3）Impact of HSCT for relapsed or refractory mantle cell lymphoma patients in the rituximab era Satoshi Yamasaki1）, Dai Chihara2）, Sung-Won Kim3）, Koji Izutsu4）, Kouji Iwato5）,
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: